MAI Capital Management
AXDX icon

MAI Capital Management’s Accelerate Diagnostics AXDX Stock Holding History

MAI Capital Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36
Closed -$26 – 3963
2025
Q1 		$26 Hold
36
– – ﹤0.01% 3402
2024
Q4 		$44 Buy
+36
New +$60 ﹤0.01% 3454

Other funds holding AXDX

BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Bartlett & Co Wealth Management
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

MAI Capital Management's AXDX Position: Q2 2025 in Review

MAI Capital Management sold out of Accelerate Diagnostics (AXDX) in Q2 2025, closing a stake of 36 shares — an estimated $26 sold.

MAI Capital Management first reported a position in AXDX in Q4 2024 and held it in 2 quarters. The position peaked at $44 in Q4 2024. 3 funds tracked by Wall St. Rank hold AXDX as of Q2 2025.

  • MAI Capital Management reported no remaining Accelerate Diagnostics position as of Q2 2025 after selling out during the quarter.
  • MAI Capital Management sold 36 Accelerate Diagnostics shares in Q2 2025, an estimated $26.
  • MAI Capital Management first reported a position in Accelerate Diagnostics in Q4 2024 and held it in 2 quarters.
  • MAI Capital Management's Accelerate Diagnostics position peaked at $44 in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2025.

Based on MAI Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.